MFN2 and pulmonary arterial hypertension: Indeed, our laboratory has found upregulated expression of DRP1 in both PAH and cancer cells with a parallel decrease in the expression of MFN2 in both PAH PASMC (Marsboom et al., 2012a) and lung cancers (Rehman et al., 2012).